FDA Inspection 1085309 — Eurofins Biopharma Product Testing India Private Ltd.
The FDA completed an inspection of Eurofins Biopharma Product Testing India Private Ltd. on Feb 27, 2019 in Bengaluru. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 27, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bengaluru (India)